DG INNOVATE PLC Logo

DG INNOVATE PLC

Develops sustainable technologies for electric mobility and energy storage solutions.

DGI | IL

Overview

Corporate Details

ISIN(s):
GB00BMZ3D204 (+2 more)
LEI:
21380058VQBP76M7TN11
Country:
United Kingdom
Address:
15 VICTORIA MEWS COTTINGLEY BUSINESS PARK, BD16 1PY BINGLEY

Description

DG Innovate PLC is an advanced research and development company pioneering sustainable and environmentally considerate technologies for electric mobility and energy storage. The company focuses on developing proprietary solutions, including ultra-high performance electric drive systems and advanced energy storage materials. Its key product portfolio features the Pareta® e-drive, a novel motor technology designed for electric vehicles. DG Innovate's work targets the sustainable transportation and energy sectors, leveraging its expertise in material science and electric motor innovation to create next-generation solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2019-01-18 08:01
Interim Results for the six months to 30 June 2018
English HTML 123.1 KB
2019-01-18 08:00
Heads of Agreement
English HTML 18.0 KB
2018-12-31 01:00
2018 Final Results
English PDF 409.1 KB
2018-11-05 08:00
Withdrawal from proposed Farm-in Agreement
English HTML 13.8 KB
2018-10-10 18:00
Schedule One Update - Path Investments Plc
English HTML 28.6 KB
2018-09-25 11:45
Sch 1 Update - Path Investments Plc
English HTML 28.5 KB
2018-08-06 19:30
Schedule One - Path Investments Plc
English HTML 29.4 KB
2018-08-03 09:00
Notice of AGM
English HTML 11.3 KB
2018-06-30 02:00
Interim Report
English PDF 198.5 KB
2018-06-29 09:00
General Meeting Statement
English HTML 12.0 KB
2018-06-04 17:49
Annual Report and Notice of GM (Replacement)
English HTML 13.3 KB
2018-06-04 16:13
Availability of Annual Report and Notice of AGM
English HTML 12.5 KB
2018-06-04 16:08
Annual Results for the year ended 31 December 2017
English HTML 342.5 KB
2018-05-25 16:57
Company Update
English HTML 14.1 KB
2018-03-28 09:00
Update re Intended Standard Listing cancellation
English HTML 13.2 KB

Automate Your Workflow. Get a real-time feed of all DG INNOVATE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DG INNOVATE PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DG INNOVATE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.